Liquidia Corp’s recent filing unveils that its Chief Medical Officer Saggar Rajeev unloaded Company’s shares for reported $22558.0 on Apr 19 ’24. In the deal valued at $13.68 per share,1,649 shares were sold. As a result of this transaction, Saggar Rajeev now holds 211,672 shares worth roughly $2.65 million.
Then, JEFFS ROGER sold 8,360 shares, generating $121,889 in total proceeds. Upon selling the shares at $14.58, the Chief Executive Officer now owns 826,985 shares.
Before that, Kaseta Michael sold 3,136 shares. Liquidia Corp shares valued at $45,723 were divested by the CFO and COO at a price of $14.58 per share. As a result of the transaction, Kaseta Michael now holds 315,045 shares, worth roughly $3.95 million.
Needham reiterated its Liquidia Corp [LQDA] rating to a Buy in a research note published on January 05, 2024; the price target was $28. Wedbush also remained covering LQDA and has decreased its forecast on September 01, 2022 with a “an Underperform” recommendation from previously “Neutral” rating. Ladenburg Thalmann started covering the stock on July 22, 2022. It rated LQDA as “a Buy”.
Price Performance Review of LQDA
On Friday, Liquidia Corp [NASDAQ:LQDA] saw its stock jump 1.29% to $12.53. Over the last five days, the stock has lost -5.72%. Liquidia Corp shares have risen nearly 4.16% since the year began. Nevertheless, the stocks have risen 85.36% over the past one year. While a 52-week high of $16.99 was reached on 03/22/24, a 52-week low of $5.71 was recorded on 01/25/24. SMA at 50 days reached $14.51, while 200 days put it at $9.92. A total of 0.53 million shares were traded, compared to the trading of 1.13 million shares in the previous session.
Levels Of Support And Resistance For LQDA Stock
The 24-hour chart illustrates a support level at 12.29, which if violated will result in even more drops to 12.06. On the upside, there is a resistance level at 12.68. A further resistance level may holdings at 12.84. The Relative Strength Index (RSI) on the 14-day chart is 32.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.15, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.61%. Stochastics %K at 12.34% indicates the stock is a buying.
The most recent change occurred on May 31, 2022 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $14 price target.
